10 Firms Close Shortened Trading Week Higher

Page 9 of 9

1. Royalty Pharma Plc (NASDAQ:RPRX)

Royalty Pharma (RPRX) saw its share prices jump by 12.56 percent on Friday to end the trading week at $29.49 apiece following news that it would acquire its external manager RP Management, as it seeks to simplify its corporate structure.

On a financial basis, the acquisition is expected to generate cash savings of more than $100 million in 2026, and over $175 million in 2030, and drive cumulative savings higher than $1.6 billion over ten years.

Royalty Pharma (RPRX) said its decision followed investors’ feedback that the current structure made it difficult to invest in the healthcare firm, and shifting to internal management could enhance the company’s valuation over time.

Since its inception in 1996, RP Management has externally controlled and managed Royalty Pharma’s (RPRX) day-to-day operations in exchange for a quarterly fee.

While we acknowledge the potential of RPRX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than RPRX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock

Disclosure: None. This article is originally published at Insider Monkey.

Page 9 of 9